Innoviz (INVZ) CFO Cegla Eldar Receives RSUs & Options

What Happened

• Cegla Eldar Mordechay, Chief Financial Officer of Innoviz Technologies (INVZ), received equity compensation on August 4, 2026: 73,184 Restricted Share Units (RSUs) and 78,416 derivative awards (stock options), both granted at $0.00 (no cash paid). Total securities granted: 151,600.
• These are awards/retention grants (not open-market purchases or sales). RSUs represent contingent rights to receive one ordinary share upon vesting; the derivative awards are share options subject to similar vesting terms.

Key Details

• Transaction date: August 4, 2026; Form 4 filed August 5, 2026 (timely).
• Price: $0.00 for both grants (no cash exchanged).
• Vesting: For the new RSUs and the new options, one-fourth vests on August 4, 2027 with the remainder vesting quarterly through 2030, subject to remaining a service provider on each vesting date.
• Shares owned/issuable after transaction: Footnote states 234,628 ordinary shares are issuable upon vesting of existing RSUs (this total includes the newly granted 73,184 RSUs).
• Footnotes: RSUs convert to one ordinary share on vesting; vesting is service-condition based. The second grant is reported as a derivative award (options) with the same vesting schedule.
• Filing timeliness: No late filing indicated.

Context

• RSUs: These convert to shares only as they vest; no immediate market sale occurred as part of these grants.
• Options (derivative award): Vest according to the schedule noted; exercise mechanics and any exercise price (if applicable) will determine future cash/ownership effects—this filing reports the grant only.
• Interpretation: Grants are compensation/retention awards and do not by themselves indicate intent to buy or sell shares; they increase potential future outstanding shares if they vest.